GCT
BSX icon

Galaxy Capital Trading’s Boston Scientific BSX Stock Holding History

Galaxy Capital Trading’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$377K Sell
31,400
-2,300
-7% -$27.2K 0.94% 37
2013
Q3 		$396K Buy
+33,700
New +$365K 0.3% 114

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Galaxy Capital Trading's BSX Position: Q4 2013 in Review

Galaxy Capital Trading reduced its Boston Scientific (BSX) stake by 6.8% in Q4 2013, selling an estimated $27.2K and leaving 31,400 shares worth $377K. The position accounts for 0.94% of the portfolio, ranked #37.

Galaxy Capital Trading first reported a position in BSX in Q3 2013 and has held it in 2 quarters since. The position peaked at $396K in Q3 2013. 450 funds tracked by Wall St. Rank hold BSX as of Q4 2013.

  • Galaxy Capital Trading held 31,400 shares of Boston Scientific worth $377K as of Q4 2013.
  • Galaxy Capital Trading sold 2,300 Boston Scientific shares in Q4 2013, an estimated $27.2K.
  • Boston Scientific made up 0.94% of Galaxy Capital Trading's portfolio in Q4 2013, its #37 holding.
  • Galaxy Capital Trading first reported a position in Boston Scientific in Q3 2013 and has held it in 2 quarters since.
  • Galaxy Capital Trading's Boston Scientific position peaked at $396K in Q3 2013.
  • 450 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2013.

Based on Galaxy Capital Trading's 13F filing for Q4 2013, filed 26 Feb 2014.